Software Daily Summary
Software Daily Summary: What Happened on October 23, 2026
Five AI tools for prostate cancer detection backed for NHS use
Boehringer Ingelheim and Microsoft plan to test whether digital patient models can predict disease progression and outcomes in lung-health studies.
-
P
Today in brief
The NHS backed five AI tools for detecting prostate cancer.1 Boehringer Ingelheim and Microsoft will begin their clinical-research AI collaboration with lung-health studies.2
Boehringer Ingelheim and Microsoft to explore AI in clinical research
Boehringer Ingelheim and Microsoft entered a collaboration to assess AI applications in clinical research, starting with lung-health studies.2 The companies plan to evaluate whether digital patient models can predict disease progression and patient outcomes in different scenarios.2 The initial phase will test the concept’s technical and scientific feasibility in several therapeutic areas, using prototypes, modelling and evidence generation.2
Also worth knowing
-
P
Five AI tools for detecting prostate cancer received backing for use by the NHS.1
Also published
- Women in AI - an evening of practical AI learning pharmaphorum
- New AI tool maps microRNA binding sites on circular RNAs BioTechniques